Vindico Pharma Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$13M
Vindico Pharma General Information
Description
Developer of nanometer-scale particulate technologies intended for a wide range of medical diagnostic and therapeutic applications. The company is dedicated to the discovery, development, and commercialization of highly innovative products, enabling healthcare providers to advance and improve their standard of patient care
Contact Information
Website
www.vindicopharma.comCorporate Office
- A169, ASTeCC
- University of Kentucky
- Lexington, KY 40506
- United States
Corporate Office
- A169, ASTeCC
- University of Kentucky
- Lexington, KY 40506
- United States
Vindico Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 10-Oct-2016 | $13M | Completed | Generating Revenue | ||
| 3. Seed Round | 25-Feb-2015 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2011 | $900K | Completed | Generating Revenue | ||
| 1. Grant | 07-Apr-2010 | $200K | Completed | Startup |
Vindico Pharma Comparisons
Industry
Financing
Details
Vindico Pharma Competitors (18)
One of Vindico Pharma’s 18 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Gesynta Pharma | Venture Capital-Backed | Stockholm, Sweden | ||||
| Biocon | Formerly PE-Backed | Bengaluru, India | ||||
| Nevian Lifescience | Corporate Backed or Acquired | Dhaka, Bangladesh | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain |
Vindico Pharma Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| NIH Office of the Director | Government | |||
| U.S. Department of Health and Human Services | Government |
Vindico Pharma FAQs
-
When was Vindico Pharma founded?
Vindico Pharma was founded in 2007.
-
Where is Vindico Pharma headquartered?
Vindico Pharma is headquartered in Lexington, KY.
-
What industry is Vindico Pharma in?
Vindico Pharma’s primary industry is Drug Discovery.
-
Is Vindico Pharma a private or public company?
Vindico Pharma is a Private company.
-
What is the current valuation of Vindico Pharma?
The current valuation of Vindico Pharma is .
-
What is Vindico Pharma’s current revenue?
The current revenue for Vindico Pharma is .
-
How much funding has Vindico Pharma raised over time?
Vindico Pharma has raised $1.28M.
-
Who are Vindico Pharma’s investors?
NIH Office of the Director and U.S. Department of Health and Human Services have invested in Vindico Pharma.
-
Who are Vindico Pharma’s competitors?
Genentech, Gesynta Pharma, Biocon, Nevian Lifescience, and Ability Pharma are some of the 18 competitors of Vindico Pharma.
-
When was Vindico Pharma acquired?
Vindico Pharma was acquired on 10-Oct-2016.
-
Who acquired Vindico Pharma?
Vindico Pharma was acquired by Poseida Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process